1.
|
Lozano R, Naghavi M, Lim S, Shibuya K, Aboyans V, Abraham J, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2095-2128.
|
2.
|
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2197-2223.
|
3.
|
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000; 31:2080-2086.
|
4.
|
Brønnum-Hansen, H; Davidsen, M; Thorvaldsen, P; Danish MONICA Study Group. Long-term survival and causes of death after stroke. Stroke. 2001; 32:2131-2136.
|
5.
|
Becher H, Grau A, Steindorf K, Buggle F, Hacke W. Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high risk groups. J Epidemiol Biostat. 2000; 5:277-283.
|
6.
|
Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke. 2002; 33:862-875.
|
7.
|
Fu GR, Yuan W, Du W, Yang Z, Fu N, Zheng H, et al. Risk Factors Associated with Recurrent Strokes in Young and Elderly Patients: A Hospital-based Study. Int J Gerontol. 2015; 9:63-66.
|
8.
|
Wangqin R, Wang X, Wang Y, Xian Y, Zhao X, Liu L, et al. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Stroke Vasc Neurol. 2017; 2:176-183.
|
9.
|
Leoo T, Lindgren A, Petersson J, von Arbin M. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis. 2008; 25:254-260.
|
10.
|
Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: A systematic review and meta-analysis. J Clin Neurosci. 2019; 60:24-30.
|
11.
|
Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Semin Neurol. 2018; 38: 208-211.
|
12.
|
Oza R, Rundell K, Garcellano M. Recurrent Ischemic Stroke: Strategies for Prevention. Am Fam Physician. 2017; 96: 436-440.
|
13.
|
Rauch G, Kunzmann K, Kieser M, Wegscheider K, König J, Eulenburg C. A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance. Stat Med. 2018; 37:749-767.
|
14.
|
Ozga AK, Rauch G. Introducing a new estimator and test for the weighted all-cause hazard ratio. BMC Med Res Methodol. 2019; 19:1-16.
|
15.
|
Becher H, Palm F, Aigner A, Safer A, Urbanek C, Buggle F, et al. Socioeconomic Conditions in Childhood, Adolescence, and Adulthood and the Risk of Ischemic Stroke. Stroke. 2016; 47:173-179.
|
16.
|
Palm F, Urbanek C, Rose S, Buggle F, Bode B, Hennerici MG, et al. Stroke Incidence and Survival in Ludwigshafen am Rhein, Germany: the Ludwigshafen Stroke Study (LuSSt). Stroke. 2010; 41:1865-1870.
|
17.
|
Truelsen T, Begg S, Methers C. The global burden of cerebrovascular disease. https://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf. Accessed 8 March 2019
|
18.
|
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390:1211-1259.
|
19.
|
Fay MP. Comparing Several Score Tests for Interval Censored Data. Stat Med. 1999; 18:273-285.
|
20.
|
Finkelstein DM. A Proportional Hazards Model for Interval-Censored Failure Time Data. Biometrics. 1986; 42:845-854.
|
21.
|
Finkelstein MD, Wolfe RA. A Semiparametric Model for Regression Analysis of Interval-Censored Failure Time Data. Biometrics. 1985; 41:933-945.
|
22.
|
Lindsey JC, Ryan LM. Tutorial in biostatistics methods for interval-censored data. Stat Med. 1998; 17:219-238.
|
23.
|
R Core Team. R: A Language and Environment for Statistical Computing (Version 3.5.1). http://www.R-project.org/. Accessed March 2019
|
24.
|
Matsumoto M, Nishimura T. Mersenne twister. A 623-dimensionally equidistributed uniform pseudorandom number generator. ACM Trans Model Comput Simul. 1998; 8:3-30.
|
25.
|
Amerenco P, Lavallée PC, Labreuche J, Albers GW, Bornstein NM, Canhão P, et al. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med. 2016; 374:1533-1542.
|